Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Free Cash Flow (2019 - 2025)

IDEAYA Biosciences' Free Cash Flow history spans 7 years, with the latest figure at -$92.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 24.86% year-over-year to -$92.2 million; the TTM value through Dec 2025 reached -$73.5 million, up 70.78%, while the annual FY2025 figure was -$73.5 million, 70.78% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$92.2 million at IDEAYA Biosciences, down from $143.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $143.6 million in Q3 2025 and bottomed at -$122.8 million in Q4 2024.
  • The 5-year median for Free Cash Flow is -$27.6 million (2022), against an average of -$29.3 million.
  • The largest annual shift saw Free Cash Flow crashed 370.05% in 2024 before it surged 388.94% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$14.7 million in 2021, then crashed by 38.08% to -$20.3 million in 2022, then decreased by 28.58% to -$26.1 million in 2023, then crashed by 370.05% to -$122.8 million in 2024, then grew by 24.86% to -$92.2 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Free Cash Flow are -$92.2 million (Q4 2025), $143.6 million (Q3 2025), and -$63.1 million (Q2 2025).